143 related articles for article (PubMed ID: 7344123)
21. Association between HLA and Sjögren's syndrome in Japanese patients.
Moriuchi J; Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Sato K; Tsuji K; Arimori S
Arthritis Rheum; 1986 Dec; 29(12):1518-21. PubMed ID: 3801073
[TBL] [Abstract][Full Text] [Related]
22. [A case of myasthenia associated with rheumatoid arthritis and Sjögren's syndrome].
Yoshino S; Morishige T; Fujimori J; Kawashima K
Ryumachi; 1982 Aug; 22(4):315-20. PubMed ID: 7179027
[No Abstract] [Full Text] [Related]
23. HL-A in Sjögren's syndrome.
Iványi D; Drízhal I; Erbenová E; Horejs J; Salavec M; Macurová H; Dostál C; Balik J; Juran J
Tissue Antigens; 1976 Jan; 7(1):45-51. PubMed ID: 1251437
[TBL] [Abstract][Full Text] [Related]
24. An abnormal T cell repertoire in hypergammaglobulinaemic primary Sjögren's syndrome.
Kay RA; Hay EM; Dyer PA; Dennett C; Green LM; Bernstein RM; Holt PJ; Pumphrey RS; Boylston AW; Ollier WE
Clin Exp Immunol; 1991 Aug; 85(2):262-4. PubMed ID: 1864006
[TBL] [Abstract][Full Text] [Related]
25. Abnormal B cell differentiation in primary Sjögren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with Serum IgG concentration.
Bohnhorst JØ; Bjørgan MB; Thoen JE; Jonsson R; Natvig JB; Thompson KM
Clin Immunol; 2002 Apr; 103(1):79-88. PubMed ID: 11987988
[TBL] [Abstract][Full Text] [Related]
26. [Pseudo-LE phenomenon in autoimmune diseases studied by the skin-window method].
Kowal E; Stasiewicz A
Pol Tyg Lek; 1973 Feb; 28(8):279-81. PubMed ID: 4120703
[No Abstract] [Full Text] [Related]
27. [Pancreatic duct antibodies in Sjogren's syndrome and in chronic polyarthritis].
Ludwig H; Schernthaner G; Scherak O; Kolarz G
Verh Dtsch Ges Rheumatol; 1978; 5():144-6. PubMed ID: 706658
[No Abstract] [Full Text] [Related]
28. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis.
Mohammed K; Pope J; Le Riche N; Brintnell W; Cairns E; Coles R; Bell DA
J Rheumatol; 2009 Sep; 36(9):1937-42. PubMed ID: 19487261
[TBL] [Abstract][Full Text] [Related]
29. Sjögren's syndrome with anticentromere antibodies.
Caramaschi P; Biasi D; Carletto A; Manzo T; Randon M; Zeminian S; Bambara LM
Rev Rhum Engl Ed; 1997 Dec; 64(12):785-8. PubMed ID: 9476266
[TBL] [Abstract][Full Text] [Related]
30. Reaction of Antiglobulin factors present in rheumatoid conditions with different gamma-globulin substrates.
Torrigiani G; Roitt IM
Rheumatology; 1975; 6():151-5. PubMed ID: 53872
[No Abstract] [Full Text] [Related]
31. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
[TBL] [Abstract][Full Text] [Related]
32. Sjögren's syndrome associated with HLA-Dw3.
Chused TM; Kassan SS; Opelz G; Moutsopoulos HM; Terasaki PI
N Engl J Med; 1977 Apr; 296(16):895-7. PubMed ID: 846509
[TBL] [Abstract][Full Text] [Related]
33. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
[TBL] [Abstract][Full Text] [Related]
34. [Allergic disorders in primary Sjögren's syndrome].
Aoki A; Hagiwara E; Ono S; Ueda A; Tsuji T; Inoue Y; Ono M; Nagaoka S; Ishigatsubo Y
Arerugi; 2002 Apr; 51(4):371-4. PubMed ID: 12014028
[No Abstract] [Full Text] [Related]
35. [Sjogren's syndrome, diffuse pulmonary fibrosis and circulating intermediate complexes].
Astorga G; Andreis M; Gruenwald H; Silva C; Schiaffino M
Rev Med Chil; 1970; 98(9):633-6. PubMed ID: 5509801
[No Abstract] [Full Text] [Related]
36. Ulcerative colitis and Sjogren's syndrome in the same patient: report of two cases and a review of the literature.
Triantafillidis JK; Roussou P; Manousos ON; Dadioti P; Nicolakis D
Ital J Gastroenterol; 1994; 26(6):299-302. PubMed ID: 7949267
[TBL] [Abstract][Full Text] [Related]
37. Serum beta-2-microglobulin in Sjögren's syndrome.
Ström T; Evrin PE; Karlsson A
Scand J Rheumatol; 1978; 7(2):97-100. PubMed ID: 81519
[TBL] [Abstract][Full Text] [Related]
38. Structure and function of beta2-microglobulin.
Kubo RT; Grey HM
Contemp Top Immunobiol; 1976; 5():267-95. PubMed ID: 61099
[No Abstract] [Full Text] [Related]
39. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
40. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
Ebo D; DeClerck LS; Bridts CH; Stevens WJ
In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
